Jablonka, E, Lamb, MJ. The changing concept of epigenetics. Ann N Y Acad Sci. 2002; 981, 82–96.
Blewitt, M, Whitelaw, E. The use of mouse models to study epigenetics. Cold Spring Harb Perspect Biol. 2013; 5, a017939.
Rosenfeld, CS. Animal models to study environmental epigenetics. Biol Reprod. 2010; 82, 473–488.
Poulsen, P, Esteller, M, Vaag, A, Fraga, MF. The epigenetic basis of twin discordance in age-related diseases. Pediatr Res. 2007; 61(5 Pt 2), 38R–42R.
Castillo-Fernandez, JE, Spector, TD, Bell, JT. Epigenetics of discordant monozygotic twins: implications for disease. Genome Med. 2014; 6, 60.
Marx, V. Epigenetics: reading the second genomic code. Nature. 2012; 491, 143–147.
Jang, HS, Shin, WJ, Lee, JE, Do, JT. CpG and non-CpG methylation in epigenetic gene regulation and brain function. Genes (Basel). 2017; 8, 148.
Zhong, X. Comparative epigenomics: a powerful tool to understand the evolution of DNA methylation. New Phytol. 2016; 210, 76–80.
Tessarz, P, Kouzarides, T. Histone core modifications regulating nucleosome structure and dynamics. Nat Rev Mol Cell Biol. 2014; 15, 703–708.
Zhang, T, Cooper, S, Brockdorff, N. The interplay of histone modifications – writers that read. EMBO Rep. 2015; 16, 1467–1481.
Du, J, Johnson, LM, Jacobsen, SE, Patel, DJ. DNA methylation pathways and their crosstalk with histone methylation. Nat Rev Mol Cell Biol. 2015; 16, 519–532.
Cora, D, Re, A, Caselle, M, Bussolino, F. MicroRNA-mediated regulatory circuits: outlook and perspectives. Phys Biol. 2017; 14, 045001.
Karlsson, O, Baccarelli, AA. Environmental health and long non-coding RNAs. Curr Environ Health Rep. 2016; 3, 178–187.
Barker, DJ. The fetal and infant origins of adult disease. BMJ. 1990; 301, 1111.
Gluckman, PD, Hanson, MA, Cooper, C, Thornburg, KL. Effect of in utero and early-life conditions on adult health and disease. N Engl J Med. 2008; 359, 61–73.
Barouki, R, Gluckman, PD, Grandjean, P, Hanson, M, Heindel, JJ. Developmental origins of non-communicable disease: implications for research and public health. Environ Health. 2012; 11, 42.
Lillycrop, KA, Phillips, ES, Jackson, AA, Hanson, MA, Burdge, GC. Dietary protein restriction of pregnant rats induces and folic acid supplementation prevents epigenetic modification of hepatic gene expression in the offspring. J Nutr. 2005; 135, 1382–1386.
Weaver, IC, Cervoni, N, Champagne, FA, et al. Epigenetic programming by maternal behavior. Nat Neurosci. 2004; 7, 847–854.
Park, JH, Stoffers, DA, Nicholls, RD, Simmons, RA. Development of type 2 diabetes following intrauterine growth retardation in rats is associated with progressive epigenetic silencing of Pdx1. J Clin Invest. 2008; 118, 2316–2324.
Sandovici, I, Smith, NH, Nitert, MD, et al. Maternal diet and aging alter the epigenetic control of a promoter-enhancer interaction at the Hnf4a gene in rat pancreatic islets. Proc Natl Acad Sci USA. 2011; 108, 5449–5454.
Ferland-McCollough, D, Fernandez-Twinn, DS, Cannell, IG, et al. Programming of adipose tissue miR-483-3p and GDF-3 expression by maternal diet in type 2 diabetes. Cell Death Differ. 2012; 19, 1003–1012.
Maloyan, A, Muralimanoharan, S, Huffman, S, et al. Identification and comparative analyses of myocardial miRNAs involved in the fetal response to maternal obesity. Physiol Genomics. 2013; 45, 889–900.
Chambers, JC, Loh, M, Lehne, B, et al. Epigenome-wide association of DNA methylation markers in peripheral blood from Indian Asians and Europeans with incident type 2 diabetes: a nested case-control study. Lancet Diabetes Endocrinol. 2015; 3, 526–534.
Dayeh, T, Tuomi, T, Almgren, P, et al. DNA methylation of loci within ABCG1 and PHOSPHO1 in blood DNA is associated with future type 2 diabetes risk. Epigenetics. 2016; 11, 482–488.
Demerath, EW, Guan, W, Grove, ML, et al. Epigenome-wide association study (EWAS) of BMI, BMI change and waist circumference in African American adults identifies multiple replicated loci. Hum Mol Genet. 2015; 24, 4464–4479.
Dick, KJ, Nelson, CP, Tsaprouni, L, et al. DNA methylation and body-mass index: a genome-wide analysis. Lancet. 2014; 383, 1990–1998.
Pan, H, Lin, X, Wu, Y, et al. HIF3A association with adiposity: the story begins before birth. Epigenomics. 2015; 7, 937–950.
Soriano-Tarraga, C, Jimenez-Conde, J, Giralt-Steinhauer, E, et al. Epigenome-wide association study identifies TXNIP gene associated with type 2 diabetes mellitus and sustained hyperglycemia. Hum Mol Genet. 2016; 25, 609–619.
Wang, B, Gao, W, Li, J, et al. Methylation loci associated with body mass index, waist circumference, and waist-to-hip ratio in Chinese adults: an epigenome-wide analysis. Lancet. 2016; 388(Suppl. 1), S21.
Wang, S, Song, J, Yang, Y, et al. HIF3A DNA methylation is associated with childhood obesity and ALT. PLoS One. 2015; 10, e0145944.
Wahl, S, Drong, A, Lehne, B, et al. Epigenome-wide association study of body mass index, and the adverse outcomes of adiposity. Nature. 2017; 541, 81–86.
Relton, CL, Davey Smith, G. Two-step epigenetic Mendelian randomization: a strategy for establishing the causal role of epigenetic processes in pathways to disease. Int J Epidemiol. 2012; 41, 161–176.
Barres, R, Kirchner, H, Rasmussen, M, et al. Weight loss after gastric bypass surgery in human obesity remodels promoter methylation. Cell Rep. 2013; 3, 1020–1027.
Benton, MC, Johnstone, A, Eccles, D, et al. An analysis of DNA methylation in human adipose tissue reveals differential modification of obesity genes before and after gastric bypass and weight loss. Genome Biol. 2015; 16, 8.
Multhaup, ML, Seldin, MM, Jaffe, AE, et al. Mouse-human experimental epigenetic analysis unmasks dietary targets and genetic liability for diabetic phenotypes. Cell Metab. 2015; 21, 138–149.
Clarke-Harris, R, Wilkin, TJ, Hosking, J, et al. PGC1alpha promoter methylation in blood at 5-7 years predicts adiposity from 9 to 14 years (EarlyBird 50). Diabetes. 2014; 63, 2528–2537.
Godfrey, KM, Sheppard, A, Gluckman, PD, et al. Epigenetic gene promoter methylation at birth is associated with child’s later adiposity. Diabetes. 2011; 60, 1528–1534.
Sharp, GC, Lawlor, DA, Richmond, RC, et al. Maternal pre-pregnancy BMI and gestational weight gain, offspring DNA methylation and later offspring adiposity: findings from the Avon Longitudinal Study of Parents and Children. Int J Epidemiol. 2015; 44, 1288–1304.
Tobi, EW, Goeman, JJ, Monajemi, R, et al. DNA methylation signatures link prenatal famine exposure to growth and metabolism. Nat Commun. 2014; 5, 5592.
Dominguez-Salas, P, Moore, SE, Baker, MS, et al. Maternal nutrition at conception modulates DNA methylation of human metastable epialleles. Nat Commun. 2014; 5, 3746.
Rando, OJ, Simmons, RA. I’m eating for two: parental dietary effects on offspring metabolism. Cell. 2015; 161, 93–105.
Godfrey, KM, Reynolds, RM, Prescott, SL, et al. Influence of maternal obesity on the long-term health of offspring. Lancet Diabetes Endocrinol. 2017; 5, 53–64.
Donkin, I, Versteyhe, S, Ingerslev, LR, et al. Obesity and bariatric surgery drive epigenetic variation of spermatozoa in humans. Cell Metab. 2016; 23, 369–378.
Kuhnen, P, Handke, D, Waterland, RA, et al. Interindividual variation in DNA methylation at a putative POMC metastable epiallele is associated with obesity. Cell Metab. 2016; 24, 502–509.
Perco, P, Wilflingseder, J, Bernthaler, A, et al. Biomarker candidates for cardiovascular disease and bone metabolism disorders in chronic kidney disease: a systems biology perspective. J Cell Mol Med. 2008; 12, 1177–1187.
Shu, L, Zhao, Y, Kurt, Z, et al. Mergeomics: multidimensional data integration to identify pathogenic perturbations to biological systems. BMC Genomics. 2016; 17, 874.
Levy, M, Thaiss, CA, Elinav, E. Metabolites: messengers between the microbiota and the immune system. Genes Dev. 2016; 30, 1589–1597.
Mischke, M, Plosch, T. The gut microbiota and their metabolites: potential implications for the host epigenome. Adv Exp Med Biol. 2016; 902, 33–44.
Thorburn, AN, Macia, L, Mackay, CR. Diet, metabolites, and “western-lifestyle” inflammatory diseases. Immunity. 2014; 40, 833–842.
Berding, K, Donovan, SM. Microbiome and nutrition in autism spectrum disorder: current knowledge and research needs. Nutr Rev. 2016; 74, 723–736.
Shapiro, H, Thaiss, CA, Levy, M, Elinav, E. The cross talk between microbiota and the immune system: metabolites take center stage. Curr Opin Immunol. 2014; 30, 54–62.
Cortese, R, Lu, L, Yu, Y, Ruden, D, Claud, EC. Epigenome-microbiome crosstalk: a potential new paradigm influencing neonatal susceptibility to disease. Epigenetics. 2016; 11, 205–215.
Yu, DH, Gadkari, M, Zhou, Q, et al. Postnatal epigenetic regulation of intestinal stem cells requires DNA methylation and is guided by the microbiome. Genome Biol. 2015; 16, 211.
Kumar, H, Lund, R, Laiho, A, et al. Gut microbiota as an epigenetic regulator: pilot study based on whole-genome methylation analysis. mBio. 2014; 5, e02113–14.
Bierne, H, Hamon, M, Cossart, P. Epigenetics and bacterial infections. Cold Spring Harb Perspect Med. 2012; 2, a010272.
Paschos, K, Allday, MJ. Epigenetic reprogramming of host genes in viral and microbial pathogenesis. Trends Microbiol. 2010; 18, 439–447.
Bonder, MJ, Kurilshikov, A, Tigchelaar, EF, et al. The effect of host genetics on the gut microbiome. Nat Genet. 2016; 48, 1407–1412.
Turpin, W, Espin-Garcia, O, Xu, W, et al. Association of host genome with intestinal microbial composition in a large healthy cohort. Nat Genet. 2016; 48, 1413–1417.
Beaumont, M, Goodrich, JK, Jackson, MA, et al. Heritable components of the human fecal microbiome are associated with visceral fat. Genome Biol. 2016; 17, 189.
Goodrich, JK, Waters, JL, Poole, AC, et al. Human genetics shape the gut microbiome. Cell. 2014; 159, 789–799.
Takahashi, K, Sugi, Y, Hosono, A, Kaminogawa, S. Epigenetic regulation of TLR4 gene expression in intestinal epithelial cells for the maintenance of intestinal homeostasis. J Immunol. 2009; 183, 6522–6529.
Takahashi, K, Sugi, Y, Nakano, K, et al. Epigenetic control of the host gene by commensal bacteria in large intestinal epithelial cells. J Biol Chem. 2011; 286, 35755–35762.
Liu, S, da Cunha, AP, Rezende, RM, et al. The host shapes the gut microbiota via fecal microRNA. Cell Host Microbe. 2016; 19, 32–43.
Schroeder, BO, Backhed, F. Signals from the gut microbiota to distant organs in physiology and disease. Nat Med. 2016; 22, 1079–1089.
Remely, M, Haslberger, AG. The microbial epigenome in metabolic syndrome. Mol Aspects Med. 2016; 54, 71–77.
Krautkramer, KA, Kreznar, JH, Romano, KA, et al. Diet-microbiota interactions mediate global epigenetic programming in multiple host tissues. Mol Cell. 2016; 64, 982–992.
Worthley, DL, Whitehall, VL, Le Leu, RK, et al. DNA methylation in the rectal mucosa is associated with crypt proliferation and fecal short-chain fatty acids. Dig Dis Sci. 2011; 56, 387–396.
Remely, M, Aumueller, E, Merold, C, et al. Effects of short chain fatty acid producing bacteria on epigenetic regulation of FFAR3 in type 2 diabetes and obesity. Gene. 2014; 537, 85–92.
Lukovac, S, Belzer, C, Pellis, L, et al. Differential modulation by Akkermansia muciniphila and Faecalibacterium prausnitzii of host peripheral lipid metabolism and histone acetylation in mouse gut organoids. mBio. 2014; 5, e01438–14.
Lynch, SV, Pedersen, O. The human intestinal microbiome in health and disease. N Engl J Med. 2016; 375, 2369–2379.
Zmora, N, Zeevi, D, Korem, T, Segal, E, Elinav, E. Taking it personally: personalized utilization of the human microbiome in health and disease. Cell Host Microbe. 2016; 19, 12–20.
Ahmad, I, Nasiruddin, M, Khan, MA, et al. Nutraceuticals as chemopreventive and therapeutic agents in gut associated pathogenesis. Biochem Anal Biochem. 2016; 5, 298.
Remely, M, Ferk, F, Sterneder, S, et al. EGCG prevents high fat diet-induced changes in gut microbiota, decreases of DNA strand breaks, and changes in expression and DNA methylation of Dnmt1 and MLH1 in C57BL/6J male mice. Oxid Med Cell Longev. Epub 2017 Jan 4.